Morgan Stanley initiated coverage of GW Pharmaceuticals (Nasdaq: GWPH) with an Overweight rating and a price target of $103 sending the stock price soaring $15.88 to $61.92.
Coverage Initiated On GW Pharmaceuticals
April 22, 2014 at 13:56 PM EDT
Coverage Initiated On GW PharmaceuticalsApril 22, 2014 at 13:56 PM EDT
Morgan Stanley initiated coverage of GW Pharmaceuticals (Nasdaq: GWPH) with an Overweight rating and a price target of $103 sending the stock price soaring $15.88 to $61.92. Related Stocks:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|